Blog

Avandia Recall Suggested by the FDA Due To Heart Attacks and Heart Failure

The FDA has urged GlaxoSmithKline to recall the popular diabetes II drug Avandia according private documentation released to the New York Times for a recent article.

According to the article if all Diabetes II patients were switched from Avandia to a similar pill named Actos there would approximately 500 less heart attacks and 300 less cases of heart failure every month. 

Avandia is also known by its generic name Riziglitazone.  Both Avandia and Riziglitazone have been linked to heart attacks, heart failure and many other dangerous side effects.  You may be wondering why has the FDA not recalled Avandia yet.  The reason Avandia has not been recalled as of yet is because the FDA can only make suggestions that a drug is dangerous and ultimately black box the drug for having known dangerous side effects.  Black boxing is when the FDA demands that a label listing all of the drugs known dangerous and possibly deadly side effects on the box so that the consumer is well aware of the problems that other people have had with the drug.  Avandia was black boxed by the FDA in 2007 but GlaxoSmithKline continues to sell and promote the diabetes II product.

If you are on Avandia it is ultimately up to you if you would like to stop taking it or not after hearing this possibly alarming information but if you have suffered similar severe heart related side effects such as a heart attack or if you have a family member who suffered heart failure and was on Avandia it may very well be possible that the heart injury or death was because of Avandia. 

For more information on what Avandia users should do if they have experienced heart related issues contact us and we will be more than happy to answer all of your legal questions.